Due to the expansion of NCATS’ compound libraries and the commercial availability of many small molecules from the original NCATS Small Molecule Repository (SMR), NCATS has sunsetted the SMR. As of Jan. 1, 2017, the Center no longer will supply compounds and NIH Clinical Collection sets. Staff will process SMR orders placed prior to Dec. 31, 2016, and investigators can expect delivery by Jan. 31, 2017. The SMR website will remain accessible through Jan. 31, 2017, and then will permanently shut down. Visit NCATS’ compound libraries page for more information.
-
Research
-
- Funding & Notices
-
- News & Media
- About Translation
-
- About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- Stem Cell Translation Laboratory
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- Early Translation Branch (ETB)
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- A Translational Approach to Addressing COVID-19
- Antiviral Program for Pandemics
- Clinical Trial Readiness for Rare Diseases, Disorders and Syndromes
- Multidisciplinary Machine-Assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey
- National COVID Cohort Collaborative (N3C)
- The Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (BGTC)
- NIH Common Fund Programs
- Rare Diseases Registry Program (RaDaR)
- Tissue Chip for Drug Screening
- Toxicology in the 21st Century (Tox21)
- Functional Genomics Lab
- Therapeutics for Rare and Neglected Diseases (TRND)
- About NCATS
- Home
- News & Media
- Stories & Publications
- NCATS E-Newsletter
- Past E-Newsletter Issues
- NCATS Closes Small Molecule Repository
NCATS Closes Small Molecule Repository
- News & Media
- Funding & Notices
-